China’s High-Risk Cholesterol Patients Are Falling Through the Cracks, Study Says
Listen to the full version
More than 60% of Chinese outpatients with abnormal blood lipid levels are not receiving treatment, according to a sweeping new study that highlights a severe gap in managing the country’s high-risk cardiovascular patients.
The research, published recently in the journal BMC Medicine, exposes a troubling paradox in China’s healthcare system: the higher a patient’s risk for cardiovascular events, the less likely their lipid levels are to be kept under control.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Save an extra $50. Introductory offer for new readers. Subscribe now.
- DIGEST HUB
Digest Hub
Back
- >60% Chinese outpatients with dyslipidemia untreated (63.7% overall), per BMC Medicine study of 604,250 from 1,785 hospitals.
- Poorest lipid control in middle-aged (36-65), obese, urban residents, high-GDP provinces.
- Control rates fall with risk: >95% low-risk to 5-15% very high-risk; urges risk-stratified interventions.
1. More than 60% of Chinese outpatients with abnormal blood lipid levels receive no treatment, revealing a major gap in cardiovascular risk management [para. 1].
2. A recent BMC Medicine study highlights a paradox: higher cardiovascular risk correlates with poorer lipid control in China's healthcare [para. 2][para. 7].
3. Titled “Lipid levels and risk-stratified management gaps of dyslipidemia in China,” the study by Jianping Li (Peking University First Hospital) and others analyzed 604,250 outpatients from 1,785 hospitals across 28 provinces [para. 3].
4. Dyslipidemia involves abnormal total cholesterol, triglycerides, LDL-C, or HDL-C levels [para. 4].
5. Prevalence among Chinese adults ≥18 reached 35.6% in 2018, rising since 2015 and affecting all ages since the 1980s [para. 5].
6. Dyslipidemia is a key modifiable risk for ASCVD, China's top cause of death in urban/rural areas, with LDL-C as a primary factor [para. 6].
7. Guidelines advocate risk-stratified management (low/medium/high/very high-risk based on lipids, CVD history, drugs), but control worsens with risk [para. 7].
8. Burden is highest in middle-aged (36-65), obese, urban residents, and high-GDP provinces [para. 8].
9. Middle-aged patients had peak LDL-C at 3.05 mmol/L; control rates worst vs. youth, especially over 45 in medium/high-risk [para. 9].
10. Obese patients showed triglycerides at 2.59 mmol/L (vs. 2.08 mmol/L normal weight) and lowest LDL-C/non-HDL-C achievement across risks [para. 10].
11. Urban LDL-C averaged 3.04 mmol/L (vs. 2.95 rural); rural had higher triglycerides; high-GDP areas had elevated lipids and poor control [para. 11].
12. Disparities stem from urbanization: sedentary lifestyles, pollution, less activity, more restaurant/delivery food in cities; rural issues include low awareness and access [para. 12].
13. 63.7% of dyslipidemia patients untreated; treatment need: ~20% low-risk, >70% medium/high-risk, >97% very high-risk [para. 13].
14. Among treated, lipid target success: >95% low-risk, 70-90% medium-risk, 40-50% high-risk, 5-15% very high-risk [para. 14].
15. Poor high-risk control due to strict targets (LDL-C <1.8 mmol/L), comorbidities (age, obesity, hypertension, diabetes), and insufficient aggressive interventions [para. 15].
16. Researchers urge risk-stratified focus on high/very high-risk, stronger primary care, targeted programs for urban/middle-aged/obese/women [para. 16].
17. This risk-control paradox, seen globally, poses severe threats in China's large population with rising chronic diseases [para. 17].
- MOST POPULAR
Sign in with Google
Sign in with Facebook
Sign in with 财新